Figure 2.
Figure 2. My approach to ibrutinib-refractory CLL. CAR-T, chimeric antigen receptor T; FISH, fluorescence in situ hybridization.

My approach to ibrutinib-refractory CLL. CAR-T, chimeric antigen receptor T; FISH, fluorescence in situ hybridization.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal